AI
Thursday, December 17, 2020 4:41:01 PM
Very impressive as you cited. Based on this, we may see upgrades in those covering RVNC and generate new/renewed interests in larger pharma looking for novel compounds. 
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
